Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis

Authors :: V Mat'oška
M Mináriková
E Houžvičková
Eva Meluzínová
O Nyč
Martin Bojar
Miroslav Zajac
Petra Liskova
Jana Libertínová
Source :: Multiple Sclerosis Journal. 16:1529-1530
Publication Year :: 2010
Publisher :: SAGE Publications, 2010.

Subjects :: Neurology
Methylprednisolone
Interferon beta antibody
business.industry
Multiple sclerosis
medicine
Azathioprine
Neurology (clinical)
Pharmacology
medicine.disease
business
medicine.drug

Full Text Access

Tools